Q1 2026 · 13F-HR
Propel Bio Management, LLCholdings as filed
Filed 2026-05-14 · accession 0000898432-26-000369
$158.7M
Reported value
38
Positions
2026-03-31
Period end
The Brief · Propel Bio Management, LLC · Q1 2026
AI · grounded in 13F
Propel Bio Management, LLC established a new position in CORT worth $6.02M. The fund also opened new stakes in VOR for $5.59M and OBIO for $3.83M. On the sell side, the manager closed its position in NKTR, reducing exposure by $3.5M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 72651A207 | PAGP | PLAINS GP HLDGS L P | $30.2M | 19.0% | 1,272,360 | Common | SHARED |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCES INC | $11.4M | 7.17% | 3,786,425 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $9.4M | 5.90% | 841,272 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $9.2M | 5.77% | 979,698 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $6.0M | 3.80% | 147,828 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $6.0M | 3.79% | 1,329,899 | Common | SOLE |
| 929033207 | VOR | VOR BIOPHARMA INC | $5.6M | 3.52% | 314,543 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $5.6M | 3.52% | 644,421 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $5.1M | 3.20% | 4,118,321 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $4.1M | 2.61% | 131,364 | Common | SHARED |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $4.1M | 2.60% | 742,049 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $4.1M | 2.58% | 210,163 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $4.0M | 2.52% | 724,678 | Common | SOLE |
| 78397T202 | SABS | SAB BIOTHERAPEUTICS INC | $3.9M | 2.45% | 1,012,790 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $3.8M | 2.41% | 896,701 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $3.6M | 2.26% | 380,420 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $3.3M | 2.07% | 122,223 | Common | SHARED |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.2M | 2.03% | 382,375 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $3.1M | 1.95% | 341,779 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $3.0M | 1.86% | 710,988 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT INC | $2.8M | 1.76% | 215,825 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $2.6M | 1.67% | 223,802 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $2.6M | 1.66% | 282,418 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $2.6M | 1.65% | 2,344,779 | Common | SOLE |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $2.4M | 1.52% | 1,420,550 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $2.0M | 1.28% | 921,457 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $2.0M | 1.26% | 1,115,000 | Common | SOLE |
| 482929106 | KLRS | KALARIS THERAPEUTICS INC | $1.7M | 1.08% | 295,771 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.7M | 1.08% | 104,772 | Common | SOLE |
| 04746L203 | LONA | LEONABIO INC | $1.5M | 0.94% | 149,279 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $1.4M | 0.89% | 329,296 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $1.3M | 0.82% | 43,798 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $1.3M | 0.81% | 55,664 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.3M | 0.79% | 85,791 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $1.2M | 0.78% | 730,606 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $949,818 | 0.60% | 146,369 | Common | SOLE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $553,909 | 0.35% | 209,493 | Common | SOLE |
| 80401L803 | MSLE | SATELLOS BIOSCIENCE INC | $57,116 | 0.04% | 10,145 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.